This excerpt taken from the ABII 10-K filed Mar 12, 2010.
Equity in Net Income of Unconsolidated Entities
Income from equity investments accounted for under the equity method for the years ended December 31, 2009, 2008 and 2007 was $2.1 million, $0.9 million and $3.8 million, respectively. For the year ended December 31, 2009, our income from equity method investments consisted of $2.3 million from Drug Source Company, LLC offset by losses from other investments acquired during the fourth quarter of 2009. Drug Source Company was our only equity method investment in 2008 and 2007.